November 25, 2025 – Neil Klompas, CEO and President of Augurex, was featured on the Progress, Potential, and Possibilities Podcast, hosted by Dr. Ira Pastor.
In the episode “Ending Diagnostic Delays in Autoimmune Conditions,” Neil discusses how innovative biomarkers and tools like SPINEstat® (Anti-14-3-3eta Multiplex test) can help address the long diagnostic delays associated with axial spondyloarthritis (axSpA), particularly in early stages, where symptoms overlap with mechanical back pain.
Neil highlights how SPINEstat® supports clinicians in distinguishing axSpA – an inflammatory autoimmune condition impacting the lower back and spine – from mechanical back pain, a common challenge that contributes to prolonged diagnostic timelines. The test also works alongside established markers such as CRP and HLA-B27, helping provide clearer early evidence of inflammatory disease and supporting more confident clinical evaluation.
The conversation emphasizes the growing value of biomarker-based testing in helping clinicians identify inflammatory back pain earlier, improve diagnostic accuracy, and support timely patient triage and treatment in axSpA.
